Hiroshi Onogi, MD

/

Executive Vice President, Head of Clinical Development – Japan

Dr. Onogi oversees HUYABIO clinical and medical affairs in Japan and is a member of the global medical team. He is responsible for conducting company sponsored clinical studies, collaboration with medical experts and industry partners in Japan. With over 30 years experience, he brings a wealth of diverse expertise in drug development, from early stage to NDA, product launching and post-market pharmaceutical management. As a medical doctor, he has served in high-profile roles for leading international pharmaceutical companies in Japan, including Aventis Pharmaceuticals, Pharmacia Corporation, GlaxoSmithKline, Merck Serono Japan, Astra Zeneca KK, and Amgen. Dr. Onogi received his MD from the Autonomous University of Guadalajara, Mexico.